LONDON, Jan 16 (Bernama) -- Enigma Diagnostics Limited, manufacturer of a new H1N1 flu diagnostic system, is interested to open a production facility at the Penang Technology Park, possibly in September this year.

Chief Operating Officer Darren Hall said he would be going back to Malaysia next month and to have further discussions with the Malaysian Industrial Development Authority (MIDA).

On the H1N1 flu diagnostic system, he said, it was expected to be launched out of United Kingdom in September and with a high volume capacity the company planned to build, "we would have a similar product for global launch in 2011".

Enigma had entered into a commercial partnership with Glaxo to launch the system with the Glaxo brand, he told reporters here.

Hall said his main concern about building the facility in Penang was the availability of talents because as a company involved in the production of medical devices and technologies, it needed talents such as laboratory technicians, scientists, production engineers, process engineers and manufacturing managers.

In the quest for the right talent, he said, he was happy to hear that there were about 11,000 Malaysian students studying in United Kingdom.

"It would be nice to have access to the students and start some kind of early engagement like industrial placement for some of the business the company are looking for," he said.

-- BERNAMA